Sunnyvale, CA, United States of America

Jose D Alejandro

This inventor holds 42 USPTO granted patents and 8 published patent applications, plus 6 CIPO patents and 6 EPO patents, primarily in Ocular Devices. Top assignees: Terumo Kabushiki Kaisha, Nexisvision, Inc., Forsight Vision5, Inc.. Active years: 2007-2024.

USPTO Granted Patents = 42 

% Patents Active = 78.6

 

 

Average Co-Inventor Count = 6.9

ph-index = 14

Forward Citations = 1,144(Granted Patents)


Location History:

  • Menlo Park, CA (US) (2014 - 2019)
  • Parsippany, NJ (US) (2020)
  • Brisbane, CA (US) (2022)
  • Sunnyvale, CA (US) (2007 - 2024)

Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Accommodating Intraocular Lens
Contact Lenses
Anterior Segment Drug Delivery
Corneal Denervation
Therapeutic Device
Ocular Insert
Bimodular Contact Lenses
Energy Based Devices
Vision Correction
Pain Management
Anatomic Tissue Defects
Corneal Onlays
42 patents (USPTO):Explore Patents

Title: The Innovative Journey of Jose D Alejandro

Introduction: Jose D Alejandro is a renowned inventor based in Sunnyvale, CA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Jose D Alejandro holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Jose D Alejandro has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Jose D Alejandro has collaborated with top universities, innovative startups, and established corporations, fostering a culture of innovation and excellence.

Conclusion: Jose D Alejandro's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…